These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12193981)

  • 1. [Blood coagulation factor XIII: activation, substrates and structure of a transglutaminase].
    Sicker T; Hilgenfeld R
    Hamostaseologie; 2002 Feb; 22(1):20-7. PubMed ID: 12193981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules.
    Pedersen LC; Yee VC; Bishop PD; Le Trong I; Teller DC; Stenkamp RE
    Protein Sci; 1994 Jul; 3(7):1131-5. PubMed ID: 7920263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific colorimetric assay for measuring transglutaminase 1 and factor XIII activities.
    Hitomi K; Kitamura M; Alea MP; Ceylan I; Thomas V; El Alaoui S
    Anal Biochem; 2009 Nov; 394(2):281-3. PubMed ID: 19646949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of transglutaminase activity in articular chondrocytes through thrombin receptor-mediated factor XIII synthesis.
    Rosenthal AK; Mosesson MW; Gohr CM; Masuda I; Heinkel D; Seibenlist KR
    Thromb Haemost; 2004 Mar; 91(3):558-68. PubMed ID: 14983233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of functional human coagulation factor XIII A-domain in plant cell suspensions and whole plants.
    Gao J; Hooker BS; Anderson DB
    Protein Expr Purif; 2004 Sep; 37(1):89-96. PubMed ID: 15294285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel MRI and fluorescent probes responsive to the Factor XIII transglutaminase activity.
    Tei L; Mazooz G; Shellef Y; Avni R; Vandoorne K; Barge A; Kalchenko V; Dewhirst MW; Chaabane L; Miragoli L; Longo D; Neeman M; Aime S
    Contrast Media Mol Imaging; 2010; 5(4):213-22. PubMed ID: 20812289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiopathology and regulation of factor XIII.
    Ichinose A
    Thromb Haemost; 2001 Jul; 86(1):57-65. PubMed ID: 11487042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase 2 and Factor XIII catalyze distinct substrates in differentiating osteoblastic cell line: utility of highly reactive substrate peptides.
    Watanabe K; Tsunoda K; Itoh M; Fukui M; Mori H; Hitomi K
    Amino Acids; 2013 Jan; 44(1):209-14. PubMed ID: 22045386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin, a substrate for transglutaminase and factor XIII activity.
    Prince CW; Dickie D; Krumdieck CL
    Biochem Biophys Res Commun; 1991 Jun; 177(3):1205-10. PubMed ID: 1676261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitronectin is a substrate for transglutaminases.
    Sane DC; Moser TL; Pippen AM; Parker CJ; Achyuthan KE; Greenberg CS
    Biochem Biophys Res Commun; 1988 Nov; 157(1):115-20. PubMed ID: 2461707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Leu564 factor XIIIA variant results in significantly lower plasma factor XIII levels than the Pro564 variant.
    Gallivan L; Markham AF; Anwar R
    Thromb Haemost; 1999 Oct; 82(4):1368-70. PubMed ID: 10544937
    [No Abstract]   [Full Text] [Related]  

  • 12. Coagulation factor XIII variants with altered thrombin activation rates.
    Andersen MD; Kjalke M; Bang S; Lautrup-Larsen I; Becker P; Andersen AS; Olsen OH; Stennicke HR
    Biol Chem; 2009 Dec; 390(12):1279-83. PubMed ID: 19804366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Structure and function of blood coagulation factor XIII (transglutaminase)].
    Takahashi N
    Tanpakushitsu Kakusan Koso; 1987 Jul; 32(8):1041-59. PubMed ID: 2890181
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium binding of transglutaminases: a 43Ca NMR study combined with surface polarity analysis.
    Ambrus A; Bányai I; Weiss MS; Hilgenfeld R; Keresztessy Z; Muszbek L; Fésüs L
    J Biomol Struct Dyn; 2001 Aug; 19(1):59-74. PubMed ID: 11565852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XIII of blood coagulation in human monocytes.
    Muszbek L; Adány R; Szegedi G; Polgár J; Kávai M
    Thromb Res; 1985 Feb; 37(3):401-10. PubMed ID: 2859670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous activity assay of two transglutaminase isozymes, blood coagulation factor XIII and transglutaminase 2, by use of fibrinogen arrays.
    Kwon MH; Jung SH; Kim YM; Ha KS
    Anal Chem; 2011 Nov; 83(22):8718-24. PubMed ID: 21961727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of medaka (Oryzias latipes) fibrinogen gamma and its gene disruption resulting in anemia as a model fish.
    Meng Q; Watanabe Y; Tatsukawa H; Hashimoto H; Hitomi K
    J Biochem; 2022 Oct; 172(5):293-302. PubMed ID: 35997167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human plasma factor XIII: subunit interactions and activation of zymogen.
    Lorand L; Jeong JM; Radek JT; Wilson J
    Methods Enzymol; 1993; 222():22-35. PubMed ID: 8105367
    [No Abstract]   [Full Text] [Related]  

  • 19. [Deficiency of A or B subunit for coagulation factor XIII].
    Souri M; Ichinose A
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):464-7. PubMed ID: 9833543
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue transglutaminase and factor XIII in cartilage and bone remodeling.
    Aeschlimann D; Mosher D; Paulsson M
    Semin Thromb Hemost; 1996; 22(5):437-43. PubMed ID: 8989828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.